A Delaware federal court jury last week awarded Johnson & Johnson's Lifescan Inc. unit more than $5.9 million after finding that Home Diagnostics Inc. and MIT Development Corp. infringed on a Lifescan patent for technology used in blood-sugar monitors. On Friday the jury awarded Milpitas, Calif.-based Lifescan damages for lost royalties on technology the company said was used without permission by its rivals Home Diagnostics of Fort Lauderdale and Wilton, Conn.'s MIT. Defense attorneys plan to appeal.
March 30, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal court jury in Wilmington last week awarded Johnson & Johnson’s Lifescan Inc. unit more than $5.9 million after finding that Home Diagnostics Inc. and MIT Development Corp. infringed on a Lifescan patent for technology used in blood-sugar monitors.
After deliberating for a little more than eight hours, the five-woman, two-man jury on Friday awarded Lifescan the damages for lost royalties on technology the company said was used without permission by rivals Home Diagnostics and MIT.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
